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Figure1. Summary of Quality papers and reports meeting study inclusion criteria 
from National Surveys. * Data from3 PCU’s, not a National Health Survey (n=2922)
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• Current Australian rates of diabetic foot screening in primary care 
centres are ambiguous. 
From the conservative estimates of registrants with the National Diabetes 
Supply Scheme, we will be soon passing 1.1 Million Australians affected 
by all types of diabetes. The burden of disease is illustrated by estimated 
health expenditure in Australia at $1,507 Million in 2008-9 (1). The true 
burden of disease is unknown as there are many people undiagnosed 
and non -quantifiable costs of loss of quality of life. The greatest area of 
financial burden of disease is in hospitalization costs.
The introduction of International Consensus on the Diabetic Foot in one 
region of Italy made significant improvements to diabetes related foot 
care. Three measures were improved: diabetes related foot screening, 
reduced hospitalisations and major amputation rates (2). This regional 
study illustrates that the burden of diabetes- related foot disease could be 
reduced by screening for diabetes related foot complications and referral 
into specialised teams to care for the foot at high risk of amputation.
STUDY AIM
The aim of this study was to explore available literature for levels of foot 
screening in primary care settings.  The focus is on adults with type 1 or 
type 2 diabetes and not gestational diabetes or children with diabetes 
comparing the Australian data with internationally reported data.
The lack of a national database and register for Australians with 
diabetes hampers efforts to analyse diabetic foot screening levels.  The 
most recent and accurate level for Australian population review was in 
the AUSDIAB (Australian Diabetes and lifestyle survey) from 2004. See 
Figure 1. This survey reported screening in primary care to be as low as 
50%. 
Since 2004, there has not been a comparable study that reaches all the 
inclusion criteria of being based on an individual screening in a primary 
health care setting, with high quality population data.
Countries such as the United Kingdom and United States of America 
have much higher reported rates of foot screening (67-86%) recorded 
using national databases and web-based initiatives that involve patients 
and clinicians. 
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This presentation reports on foot screening rates as recorded in the 
academic literature, national health surveys and national database 
reports. It is therefore secondary data analysis.
Literature searches included diabetic foot screening that occurred in the 
primary care setting for populations over 2000 people from 2002 to 
2014. Searches were performed using Medline and CINAHL as well as 
internet searches of OECD countries health databases. The primary 
outcome measure was foot -screening rates as a percentage of adult 
diabetic population.
Records were further screened and excluded if they did not contain 
data pertaining to individuals, and had a primary outcome measure as 
percentage of health care centres performing screening or control trials 
where screening was the intervention or reported from secondary 
health care settings where foot screening and referral had occurred in 
primary health care.
Studies with poor quality for recording of diabetes related foot 
screening were further eliminated. See Table 1 for details. 
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• The most recent Australian population based studies -Australian 
Quality Clinical Audit (AQCA) nee ANDIAB (2011) and Australian 
National Diabetes Audit (2013) only record foot screening in  
secondary care centres.
• The Australian National Health Survey (ABS, 2013) used self-
reported data with low statistical quality.
• Uptake of national registers, incentives and web based systems 
improve levels of diabetic foot assessment which are the first steps 
to a healthier diabetic population.
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Table 1. Flow Diagram of literature search 
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